Method for administration of capecitabine
OwnerUte Dugan, Larry Nortoninventors
Life of this patent
Estimating the term…
Abstract
There is provided a new dosage regimen for capecitabine which maximizes anti-tumor activity while maintaining acceptable toxicity levels.
Claims10
A method of treating a patient suffering form cancer, comprising administering to said patient a pharmaceutical composition containing as an active ingredient capecitabine in an amount from about 500 mg/m2/day to about 6600 mg/m2/day for up to about 7 days, followed by a rest period of up to about 7 days, said administration starting on the first day of a 14-28 day treatment cycle said treatment cycle being repeated every 14-28 days.
A method of treating a patient suffering form cancer, comprising administering to said patient a pharmaceutical composition containing as an active ingredient capecitabine in an amount from about 500 mg/day to about 6600 mg/day, twice daily, for up to about 7 days, followed by a rest period of up to about 7 days, said administration starting on the first day of a 14-28 day treatment cycle, said treatment cycle being repeated every 14-28 days.
A method of treating a patient suffering from cancer, comprising administering to said patient a pharmaceutical composition containing as an active ingredient capecitabine in an amount from about 1000 mg/m2/day to about 2500 mg/m2/day for 7 days, followed by a rest period of 7 days, said administration starting on the first day of a 14-28 day treatment cycle, said treatment cycle being repeated every 14-28 days.
A method of treating a patient suffering form cancer, comprising administering to said patient a pharmaceutical composition containing as an active ingredient capecitabine in an amount from about 1000 mg/day to about 2500 mg/day, twice daily, for 7 days, followed by a rest period of 7 days, said administration starting on the first day of a 14-28 day treatment cycle, said treatment cycle being repeated every 14-28 days.
A method of treating a patient suffering from cancer, comprising administering to said patient a pharmaceutical composition containing as an active ingredient capecitabine in an amount from about 500 mg/m2/day to about 3000 mg/m2/day for 5 days, followed by a rest period of 2 days, said administration starting on the first day of a 7-28 day treatment cycle, said treatment cycle being repeated every 7-28 days.
A method of treating a patient suffering from cancer, comprising administering to said patient a pharmaceutical composition containing as an active ingredient capecitabine in an amount from about 500 mg/day to about 3000 mg/day, twice daily, for 5 days, followed by a rest period of 2 days, said administration starting on the first day of a 7-28 day treatment cycle, said treatment cycle being repeated every 7-28 days.
Dependencies are inferred from the claim text.